Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 10.3962 | 98 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 10.1876 | 98 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 10.1199 | 98 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 10.4027 | 98 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 10.5533 | 98 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.40264 | 95 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 8.64767 | 96 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.89449 | 96 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.76843 | 96 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 10.8002 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 11.0688 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 10.7217 | 98 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 11.0856 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.7356 | 99 |